Citations

Showing 10 of 108104 citations.

Appropriate Telemedicine Utilization in Spine Surgery
Iyer, Sravisht, Bovonratwet, Patawut, Samartzis, Dino, Schoenfeld, Andrew J., An, Howard S., Awwad, Waleed, Blumenthal, Scott L., Cheung, Jason P.Y., Derman, Peter B., El-Sharkawi, Mohammad, Freedman, Brett A., Hartl, Roger, Kang, James D., Kim, Han Jo, Louie, Philip K., Ludwig, Steven C., Neva, Marko H., Pham, Martin H., Phillips, Frank M., Qureshi, Sheeraz A., Radcliff, Kris E., Riew, K. Daniel, Sandhu, Harvinder S., Sciubba, Daniel M., Sethi, Rajiv K., Valacco, Marcelo, Zaidi, Hasan A., Zygourakis, Corinna C., Makhni, Melvin C., Iyer, Sravisht, Bovonratwet, Patawut, Samartzis, Dino , Schoenfeld, Andrew J., An, Howard S., Awwad, Waleed Mohammad , Blumenthal, Scott L., Cheung, Jason P.Y., Derman, Peter B., El-Sharkawi, Mohammad Mostafa , Freedman, Brett A., Hartl, Roger, Kang, James D., Kim, Han Jo, Louie, Philip K., Ludwig, Steven C., Neva, Marko H., Pham, Martin H., Phillips, Frank M., Qureshi, Sheeraz A., Radcliff, Kris E., Riew, K. Daniel, Sandhu, Harvinder S., Sciubba, Daniel M., Sethi, Rajiv K., Valacco, Marcelo, Zaidi, Hasan A., Zygourakis, Corinna C., Makhni, Melvin C.

Mayo Clinic

Spine | February 7, 2022 | Volume: 47 | Issue: 8 | Pages: 583-590

10.1097/brs.0000000000004339 | PMID 35125460 Get It

Study Design. Delphi expert panel consensus. Objective. To obtain expert consensus on best practices for appropriate telemedicine utilization in spine surgery. Summary of Background Data. Several studies have shown high patient satisfaction associated with telemedicine during the COVID-19 peak pandemic period as well as after easing of restrictions. As this technology will most likely continue to be employed, there is a need to define appropriate utilization. Methods. An expert panel consisting of 27 spine surgeons from various countries was assembled in February 2021. A two-round consensus-based Delphi method was used to generate consensus statements on various aspects of telemedicine (separated as video visits or audio visits) including themes, such as patient location and impact of patient diagnosis, on assessment of new patients. Topics with ≥75% agreement were categorized as having achieved a consensus. Results. The expert panel reviewed a total of 59 statements. Of these, 32 achieved consensus. The panel had consensus that video visits could be utilized regardless of patient location and that video visits are appropriate for evaluating as well as indicating for surgery multiple common spine pathologies, such as lumbar stenosis, lumbar radiculopathy, and cervical radiculopathy. Finally, the panel had consensus that video visits could be appropriate for a variety of visit types including early, midterm, longer term postoperative follow-up, follow-up for imaging review, and follow-up after an intervention (i.e., physical therapy, injection). Conclusion. Although telemedicine was initially introduced out of necessity, this technology most likely will remain due to evidence of high patient satisfaction and significant cost savings. This study was able to provide a framework for appropriate telemedicine utilization in spine surgery from a panel of experts. However, several questions remain for future research, such as whether or not an in-person consultation is necessary prior to surgery and which physical exam maneuvers are appropriate for telemedicine. Level of Evidence: 4
Stage-Specific Non-Coding RNA Expression Patterns during In Vitro Human B Cell Differentiation into Antibody Secreting Plasma Cells
Tschumper, Renee C. , Hoelzinger, Dominique B. , Walters, Denise K., Davila, Jaime , Osborne, Collin A., Jelinek, Diane F., Osborne, Collin , Davila, Jaime I, Davila, Jaime I

Mayo Clinic

Non-Coding RNA | February 6, 2022 | Volume: 8 | Issue: 1 | Pages: 15

10.3390/ncrna8010015 | PMID 35202088 Get It

The differentiation of B cells into antibody secreting plasma cells (PCs) is governed by a strict regulatory network that results in expression of specific transcriptomes along the activation continuum. In vitro models yielding significant numbers of PCs phenotypically identical to the in vivo state enable investigation of pathways, metabolomes, and non-coding (ncRNAs) not previously identified. The objective of our study was to characterize ncRNA expression during human B cell activation and differentiation. To achieve this, we used an in vitro system and performed RNA-seq on resting and activated B cells and PCs. Characterization of coding gene transcripts, including immunoglobulin (Ig), validated our system and also demonstrated that memory B cells preferentially differentiated into PCs. Importantly, we identified more than 980 ncRNA transcripts that are differentially expressed across the stages of activation and differentiation, some of which are known to target transcription, proliferation, cytoskeletal, autophagy and proteasome pathways. Interestingly, ncRNAs located within Ig loci may be targeting both Ig and non-Ig-related transcripts. ncRNAs associated with B cell malignancies were also identified. Taken together, this system provides a platform to study the role of specific ncRNAs in B cell differentiation and altered expression of those ncRNAs involved in B cell malignancies.
The incidence of torsades de pointes with peri‐operative low‐dose ondansetron administration
Nuttall, Gregory A. , Voogd, Sarah C., Danke, Heather, Warner, Paul A., Oyen, Lance J., Marienau, Mary Shirk, Ackerman, Michael J.

Mayo Clinic

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy | February 6, 2022 | Volume: 42 | Issue: 4 | Pages: 292-297

10.1002/phar.2668 | PMID 35124842 Get It

AbstractStudy ObjectiveThe primary objective of this retrospective safety study was to determine the incidence of torsades de pointes (TdP) or death following perioperative administration of low‐dose, 4 mg, ondansetron for postoperative nausea and vomiting.Design and SettingThis is a single‐center retrospective clinical trial.PatientsThe authors identified 32,737 patients who received 37,589 doses of ondansetron during a 2‐year time frame between March 2009 and February 2011 for surgical nausea prophylaxis or treatment of nausea.Measurements and Main ResultsPatients were cross‐matched with an electrocardiogram and adverse outcome database; this identified 4759 patients with documentation of a QTc >450 milliseconds (ms), all ventricular tachycardias including TdP within 48 hours of receiving ondansetron, or death within 7 days of receiving ondansetron. No patients developed TdP or died as a direct result of ondansetron administration (n = 0; event rate = 0.0 per 10,000, 95% CI 0.0 to 1.1 per 10,000). Forty‐six of 32,737 surgical patients had documented monomorphic ventricular tachycardia (VT) (n = 14; event rate = 4.3 per 10,000, 95% CI 2.3 to 7.2 per 10,000) or died (n = 32; event rate = 9.8 per 10,000, 95% CI 6.7 to 13.8 per 10,000) within 48 h of ondansetron administration. All monomorphic VT episodes were precipitated by existing cardiovascular disease; and 7 of 14 patients had documented monomorphic VT prior to receiving ondansetron. Of the 32 surgical patients who died, all deaths were precipitated by pre‐existing disease.ConclusionNo episodes of TdP were identified in patients receiving ondansetron perioperatively. This suggests that low‐dose ondansetron does not contribute to the development of TdP.
CORR Insights®: Machine Learning Can be Used to Predict Function but Not Pain After Surgery for Thumb Carpometacarpal Osteoarthritis
Pulos, Nicholas , Pulos, Nicholas

Mayo Clinic

Clinical Orthopaedics & Related Research | February 5, 2022 | Volume: 480 | Issue: 7 | Pages: 1285-1286

10.1097/corr.0000000000002139 | PMID 35122682 Get It

Consensus on Triple Endoscopy Data Elements Preparatory to Development of an Aerodigestive Registry
Boesch, R. Paul , Alarcón, Alessandro de , Prager, Jeremy D. , Rosen, Rachel , Sidell, Douglas R., Wootten, Christopher T. , Balakrishnan, Karthik , Sidell, Douglas R. , Boesch, Richard P , de Alarcón, Alessandro , Prager, Jeremy D , Sidell, Douglas R , Balakrishnan, Karthik , Rosen, Rachel , Balakrishnan, Karthik , Piccione, Joseph C.

Mayo Clinic

The Laryngoscope | February 5, 2022 | Volume: 132 | Issue: 11 | Pages: 2251-2258

10.1002/lary.30038 | PMID 35122443 Get It

Objectives/HypothesisThis study defines essential data elements to be recorded during an aerodigestive “triple endoscopy” to form the foundation of a standardized multicenter registry and to clearly define measurement of each consensus item.Study DesignModified Delphi process.MethodsModified Delphi consensus with six survey rounds. Twenty‐four expert pediatric otolaryngology, pulmonology, and gastroenterology aerodigestive clinicians from eight large academic pediatric aerodigestive programs formed the Delphi panel. After achieving consensus through the Delphi process, outside validation was performed at 2019 national Aerodigestive Society conference. Consensus, near‐consensus, or exclusion was obtained for each proposed data element. Concordance was then measured between expert panel conclusions and validation group conclusions.ResultsOverall response rate was 94.4%. 73/167 proposed items reached consensus in six domains (flexible bronchoscopy, bronchoalveolar lavage, microdirect laryngoscopy and bronchoscopy, esophagogastroduodenoscopy with biopsies, and esophageal impedance and pH probe). Measurement of all items was defined; classification/grading systems were selected for 11 items. Validation group endorsed importance of 82/167 data items; compared to expert consensus, overall, inclusion, and exclusion concordance rates were 94.5%, 98.7%, and 90.9%.ConclusionTriple endoscopy is a central component of aerodigestive care. This study identifies and defines data elements to be recorded for all triple endoscopy procedures. The list is of usable length, and clear definitions were created for all items, with explicit classification/grading systems selected for 11 items. Face validity was confirmed with an independent multispecialty sample of aerodigestive providers. This consensus provides the foundation for a triple endoscopy registry but also is immediately applicable to standardize clinical documentation in aerodigestive care.Level of Evidence5 Laryngoscope, 132:2251–2258, 2022
Fibroblast growth factor receptor (FGFR) inhibitors in cholangiocarcinoma: current status, insight on resistance mechanisms and toxicity management
Chakrabarti, Sakti , Finnes, Heidi D. , Chakrabarti, Sakti , Mahipal, Amit

Mayo Clinic

Expert Opinion on Drug Metabolism & Toxicology | February 5, 2022 | Volume: 18 | Issue: 1 | Pages: 85-98

10.1080/17425255.2022.2039118 | PMID 35129006 Get It

The Clinical Significance of Eosinophils in Ulcerative Colitis: A Systematic Review
Mookhoek, Aart , Haasnoot, Maria L. , Ma, Christopher , Pai, Rish K. , Ma, C , Jairath, Vipul , Bredenoord, Albert J. , Jairath, Vipul

Mayo Clinic

Journal of Crohn's and Colitis | February 5, 2022 | Volume: 16 | Issue: 8 | Pages: 1321-1334

10.1093/ecco-jcc/jjac024 | PMID 35136998 Get It

Abstract Background and Aims Ulcerative colitis [UC] is characterised by an unpredictable disease course and variable response to therapy. Recent studies suggest a role for eosinophils in both pathogenesis and predicting treatment response. The goal of this study was to determine the association between eosinophils and clinical outcomes in UC. Methods A systematic review of the literature from database inception to May 2021 was performed to identify all studies evaluating the relationship between eosinophils and/or eosinophil-derived proteins [EDPs] and clinical outcomes, such as disease activity, clinical relapse, severity of disease, and response to treatment. Results A total of 55 studies were identified. Of these, 34 studies evaluated the relationship between eosinophils in colonic tissue and outcomes and 15 in blood. Eighteen studies assessed the relationship between EDPs and outcomes. In 25 of 34 studies, a positive correlation between eosinophils and/or EDPs and disease activity was reported, three studies found a negative correlation, and nine studies found no correlation. Positive correlations between eosinophils and clinical relapse were shown in four of nine studies, and with disease outcome severity in five of seven studies. Four of 15 studies showed that subjects with higher eosinophil levels had a poor response to treatment. Conclusions These findings suggest that higher eosinophil levels may be associated with increased disease activity and poorer clinical outcomes and response to therapy. Future studies are needed to determine whether a distinct eosinophil-rich UC phenotype exists and whether eosinophil-targeted therapy can alter the disease course.
Concomitant Sepsis Diagnoses in Acute Myocardial Infarction-Cardiogenic Shock: 15-Year National Temporal Trends, Management, and Outcomes
Bhat, Anusha Ganapati , Patlolla, Sri Harsha , Miller, P. Elliott , Lawler, Patrick R. , Zhao, David , Vallabhajosyula, Saraschandra , Vallabhajosyula, Saraschandra , Lawler, Patrick , Harsha Patlolla, Sri , Jentzer, Jacob C. , Sinha, Shashank S , Diepen, Sean van , Khanna, Ashish K.

Mayo Clinic

Critical Care Explorations | February 4, 2022 | Volume: 4 | Issue: 2 | Pages: e0637

10.1097/cce.0000000000000637 | PMID 35141527 Get It

OBJECTIVES: Mixed cardiogenic-septic shock is common and associated with high mortality. There are limited contemporary data on concomitant sepsis in acute myocardial infarction complicated by cardiogenic shock (AMI-CS). DESIGN: Observational study. SETTING: Twenty percent stratified sample of all community hospitals (2000–2014) in the United States. PARTICIPANTS: Adults (> 18 yr) with AMI-CS with and without concomitant sepsis. INTERVENTIONS: None. MEASUREMENTS AND MAIN RESULTS: Outcomes of interest included inhospital mortality, development of noncardiac organ failure, complications, utilization of guideline-directed procedures, length of stay, and hospitalization costs. Over 15 years, 444,253 AMI-CS admissions were identified, of which 27,057 (6%) included sepsis. The sepsis cohort had more comorbidities and had higher rates of noncardiac multiple organ failure (92% vs 69%) (all p < 0.001). In 2014, compared with 2000, the prevalence of sepsis increased from 0.5% versus 11.5% with an adjusted odds ratio (aOR) 11.71 (95% CI, 9.7–14.0) in ST-segment elevation myocardial infarction and 24.6 (CI, 16.4–36.7) (all p < 0.001) in non-ST segment elevation myocardial infarction. The sepsis cohort received fewer cardiac interventions (coronary angiography [65% vs 68%], percutaneous coronary intervention [43% vs 48%]) and had greater use of mechanical circulatory support (48% vs 45%) and noncardiac support (invasive mechanical ventilation [65% vs 41%] and acute hemodialysis [12% vs 3%]) (p < 0.001). The sepsis cohort had higher inhospital mortality (44.3% vs 38.1%; aOR, 1.21; 95% CI, 1.18–1.25; p < 0.001), longer length of stay (14.0 d [7–24 d] vs 7.0 d [3–12 d]), greater hospitalization costs (×1,000 U.S. dollars) ($176.0 [$85–$331] vs $77.0 [$36–$147]), fewer discharges to home (22% vs 44%) and more discharges to skilled nursing facilities (51% vs 28%) (all p < 0.001). CONCLUSIONS: In AMI-CS, concomitant sepsis is associated with higher mortality and morbidity highlighting the need for early recognition and integrated management of mixed shock.
Lichen Planus Pemphigoides Associated With PD-1 and PD-L1 Inhibitors: A Case Series and Review of the Literature
Boyle, Margaret M. , Ashi, Shaymaa, Puiu, Tudor , Reimer, Danielle , Soltani, Keyoumars, Onajin, Oluwakemi , Sokumbi, Olayemi

Mayo Clinic

The American Journal of Dermatopathology | February 4, 2022 | Volume: 44 | Issue: 5 | Pages: 360-367

10.1097/dad.0000000000002139 | PMID 35120032 Get It

Abstract: Immune checkpoint inhibitors are increasingly being used in the treatment of various solid organ and hematologic malignancies. Dermatologic toxicities associated with programmed cell death protein-1 (PD-1) and programmed death ligand-1 (PD-L1) therapy have been widely reported in the literature. It is important for clinicians to be aware of these toxicities to ensure prompt recognition and treatment. Herein, we present the clinical, histopathologic, and immunofluorescence findings of 3 patients diagnosed with lichen planus pemphigoides (LPP) after treatment with anti-PD-1 inhibitors. We also reviewed the literature and summarize 7 previously reported cases of LPP associated with anti-PD-1 and anti-PD-L1 inhibitors. LPP was diagnosed at a median time of 24.4 weeks (range: 4–78 weeks) after initiation of immunotherapy. Clinical findings included papules, plaques, erosions, vesicles, and bullae on the trunk and extremities. Oral involvement was present in half the cases. Histopathologic features of immunotherapy-induced LPP included lichenoid or vacuolar interface dermatitis, the presence of eosinophils, and subepidermal bullae. Direct immunofluorescence demonstrated linear deposition of immunoglobulin G (IgG) or C3. Indirect immunofluorescence demonstrated linear IgG along basement membrane zone on monkey esophagus in 2 cases and linear IgG on the epidermal side of salt split skin in 3 cases. Serum anti-BP180 was elevated in all cases in which enzyme-linked immunosorbent assay was performed.
My Mother's Last Lesson
Williams, Colt , Williams, Colt

Mayo Clinic

Journal of Clinical Oncology | February 4, 2022 | Volume: 40 | Issue: 12 | Pages: 1385-1387

10.1200/jco.21.02382 | PMID 35119907 Get It